3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Neoplasms
5
Stomach Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Stomatitis
1
Spondylitis, Ankylosing
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Scleroderma, Localized
1
Psoriasis
1
Postoperative Hemorrhage
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Pancreatic Cyst
1
Pain, Postoperative
1
Pain
1
Interventions
Saline Solution
1
Infliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Depressive Disorder, Treatment-Resistant
×
Saline Solution
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts